Becton, Dickinson and Co
(NYSE:BDXB.PFD)
$
48.16
0.66 (1.39%)
Market Cap: -
Enterprise Value: -
PE Ratio: 48.87
PB Ratio: 2.65
GF Score: 79/100 Becton Dickinson and Co at JPMorgan Healthcare Conference Transcript
Jan 14, 2020 / 11:00PM GMT
Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst
Good afternoon, everyone. I'm Robbie Marcus, the medical device analyst at JPMorgan. I'm happy to introduce the President and COO and incoming CEO of Becton, Dickinson, Tom Polen, for his first presentation at JPMorgan.
Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Director
Great. Thank you, Robbie.
Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst
Thank you.
Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Director
Okay. Thank you, Robbie. And as always, it's a pleasure to be here, and thanks, everyone, for joining us. As many of you know, I'm Tom Polen, BD's President and Chief Operating Officer, and in 2 weeks, I'll transition to my new role as the next CEO of BD. It's truly an honor to lead BD in such an exciting time, and I'm happy to be here to share our plans for BD's next phase of value creation.
Before I get
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot